Syndax highlights late-stage programs and new pipeline assets
The R&D event features SNDX-4321, a novel EGFR inhibitor, and SNDX-62122, a next-generation menin inhibitor, with Phase 2 IPF data expected in 4Q26.
Latest Syndax News & Updates
See the latest news and media coverage for Syndax. We track all announcements, press releases, and industry mentions in real time, all in one place.
Commercial-stage oncology company developing targeted cancer therapies
syndax.com- Headquarters
- New York, United States
- Company type
- Public company
- Number of employees
- 50–350
- Industry
- Pharmaceuticals
Last updated
Latest news about Syndax
In short: Syndax secured multiple FDA approvals for Revuforj and Niktimvo while reporting substantial revenue growth from its oncology portfolio.
Company announcements
Syndax publishes SAVE data on Revuforj combination in AML
The all-oral regimen showed 88% ORR and 71% CRc in relapsed/refractory AML.
Syndax highlights Revuforj clinical data at EHA 2026
Data show high response rates in multiple acute leukemia subtypes and settings, including real-world and frontline combinations.
Syndax announces $250M private placement of convertible senior notes
The 2.25% notes mature in 2031, and net proceeds of ~$243M will fund R&D, commercialization, and business development.
Media coverage
Syndax Pharmaceuticals intends to announce MAXPIRe topline data as stock falls 7%
Syndax Pharmaceuticals stock falls 7% today, trading at $18.47. Traders monitor potential trend shifts while awaiting new ...
Syndax (SNDX) Sales Nearly Doubled, So Why Did The Stock Fall?
Syndax Pharmaceuticals (NASDAQ:SNDX) just posted a quarter that nearly doubled revenue, yet shares...
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates
Syndax (SNDX) delivered earnings and revenue surprises of -22.22% and -11.16%, respectively, for the...
Syndax (SNDX) Q2 2026 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Syndax Second Quarter 2026 Earnings Conference Call. Today's call is being recorded. [Operator Instructions] At this time...
Never miss news about Syndax
Track Syndax and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Syndax competitors & trending companies
Browse news for competitors to Syndax and other trending companies.
Oncopeptides
Alligator
Kura
Kestrel
BioInvent
Repertoire
SELLAS
ImmunityBio
BioLineRx
Compugen
Can-Fite
Solu
Agenus
Replimune
Zymeworks
Incyte
Aprea Therapeutics
Aura Biosciences
Active Biotech
Sprint Bioscience
Oculis
Ticketplus
HELP Therapeutics
CMC
ManpowerGroup
Arcosa
Alliance Entertainment
QXO
Reliant Stones
Amber
The Pool Tile Co
Cinajus
Armstone
Eco Outdoor
Sareen Stone
Stone Planet